You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III squamous cell carcinoma of the hypopharynx

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
Has Results
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • +3 more
  • Eliminating RT to the elective neck
  • RT standard of care
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia

Active, not recruiting
  • Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
  • Nelfinavir (Viracept®) 1250 mg
  • FMISO
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 30, 2021

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

Available
  • Cutaneous Melanoma, Stage III
  • +3 more
  • IFx-Hu2.0
  • (no location specified)
Aug 5, 2022

Stage T3 Squamous Cell Carcinomas of the Scalp

Active, not recruiting
  • Squamous Cell Carcinoma
  • +2 more
    • Maastricht, Netherlands
      Ellen Oyen
    Aug 3, 2023

    Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

    Not yet recruiting
    • Head and Neck Neoplasms
    • TransCon TLR7/8 Agonist
    • +2 more
    • (no location specified)
    Aug 4, 2023

    Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
    • (no location specified)
    Mar 17, 2023

    Active, not recruiting
    • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
    • +8 more
    • Cetuximab
    • +3 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Cancer Institute (UPCI)
    Jan 26, 2023

    Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

    Not yet recruiting
    • Metastatic Penile Squamous Cell Carcinoma
    • +3 more
    • Enfortumab Vedotin
    • Phoenix, Arizona
    • +2 more
    Oct 23, 2023

    Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Carrilizumab with albumin-binding paclitaxel
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 23, 2023

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

    Active, not recruiting
    • Laryngeal Cancer Stage II
    • +3 more
    • Amsterdam, Netherlands
      The Netherlands Cancer Institute
    Sep 27, 2022

    Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

    Recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Liuxiqiang
    Feb 1, 2023

    Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

    Recruiting
    • Lung Squamous Cell Carcinoma
    • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
    • Yancheng, Jiangsu, China
      Yancheng Clinical College of Xuzhou Medical University
    Mar 21, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III Trial in Shanghai (Neoadjuvant

    Recruiting
    • Esophageal Squamous Cell Carcinoma Stage II
    • Esophageal Squamous Cell Carcinoma Stage III
    • Neoadjuvant Chemoradiotherapy
    • +2 more
    • Shanghai, China
      Shanghai Zhongshan Hospital
    Jun 26, 2022

    Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

    Active, not recruiting
    Has Results
    • Squamous Cell Carcinoma of the Oropharynx
    • +7 more
    • Tampa, Florida
    • +2 more
    Dec 30, 2022